Laura K McMullan

8PUBLICATIONS
54CO-AUTHORS
Medical infection agents (incl. prions)Respiratory diseasesMedical virologyPharmaceutical delivery technologiesCauses and prevention of crime
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 17, 2026
AI-Driven Discovery and BSL-4 Validation of Cross-Filovirus Ebola-Marburg Inhibitors and their Synergistic Combinations.

|May 28, 2025
Evaluating Neutralizing Antibodies in Hantavirus-Infected Patients Using Authentic Virus and Recombinant Vesicular Stomatitis Virus Systems.

Punya Shrivastava-Ranjan, Jamie A Kelly, Laura K McMullan

|Nov 20, 2024
Delayed low-dose oral administration of 4'-fluorouridine inhibits pathogenic arenaviruses in animal models of lethal disease.

Stephen R Welch, Jessica R Spengler, Jonna B Westover

|Jul 27, 2022
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines.

Li Wang, Markus H Kainulainen, Nannan Jiang

|Oct 08, 2020
Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases.

Michael K Lo, César G Albariño, Jason K Perry

|Jul 25, 2019
Stable Occupancy of the Crimean-Congo Hemorrhagic Fever Virus-Encoded Deubiquitinase Blocks Viral Infection.

Florine E M Scholte, Brian L Hua, Jessica R Spengler

Pageof 2

Frequent Collaborators

4 joint publications

Mike Flint

4 joint publications

Michael K Lo

3 joint publications

Payel Chatterjee

2 joint publications

Éric Bergeron